NCT04271371 (PROSPER) is a clinical trial of Not yet developed in Smoking, sponsored by University of Nottingham.

Who is sponsoring NCT04271371?

NCT04271371 is sponsored by University of Nottingham.

What drugs are being tested in NCT04271371?

Interventions in NCT04271371: Not yet developed.

What condition does NCT04271371 study?

NCT04271371 studies Smoking, Smoking Reduction, Electronic Cigarette Use.

Is NCT04271371 still recruiting?

NCT04271371 is currently completed. Last updated 28 February 2024.

Last reviewed 2024-02-28 · How we verify

NCT04271371: PROSPER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preventing Relapse to Smoking Among Prisoners After Release

Completed Last updated 28 February 2024

What this trial tests

trial testing Not yet developed in Smoking in 40 participants. Completed in 30 December 2023.

Timeline

8 August 2019

Primary endpoint
1 May 2023

30 December 2023

Quick facts

Lead sponsor	University of Nottingham
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	8 August 2019
Primary completion	1 May 2023
Estimated completion	30 December 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Not yet developed

Conditions studied

Smoking — all drugs for Smoking →
Smoking Reduction — all drugs for Smoking Reduction →
Electronic Cigarette Use — all drugs for Electronic Cigarette Use →

Sponsor

University of Nottingham

Who can join

18 and older, male only, with Smoking or Smoking Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prisoners experience huge health inequalities, and their exceptionally high smoking prevalence (five times the national average) contributes significantly to their high mortality. Since the introduction of smoke-free polices across Her Majesty's Prison and Probation Service (HMPPS) in England and Wales, prisoners are now obliged to abstain from smoking while held in prison. This represents a unique opportunity to promote lifelong cessation in this highly disadvantaged and marginalised group. However, evidence suggests most prisoners intend to resume smoking as soon as possible after release. A systematic review of prison smoke-free polices worldwide concluded that there was a need for new research to identify effective strategies to reduce relapse in these individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other University of Nottingham trials

Trials by the same sponsor.

NCT07518381 — Medication Understanding in MS · not yet recruiting
NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04271371 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
Last refreshed: 28 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04271371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing